Galux teams with GC Biopharma to fast-track AI antibody drugs

--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-04-21 14:06 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: Technology & AI, Drugs, World News, Technology
--------------------------------------------------------------------
Snippet:
Galux, an AI-driven biotech startup specializing in de novo antibody design, said Tuesday it has partnered with GC Biopharma to develop antibody therapeutics for autoimmune diseases.
--------------------------------------------------------------------
>>> Read full article at The Korea Herald <<<
<-- Back to Home
< >
[Close]